Literature DB >> 20393760

Repetition of continuous PTH treatments followed by periodic withdrawals exerts anabolic effects on rat bone.

Masaya Etoh1, Akira Yamaguchi.   

Abstract

Various animal experiments and human studies have shown that intermittent injections of parathyroid hormone (PTH) exert anabolic effects on bone, whereas continuous PTH treatment decreases the bone mass and causes hypercalcemia in animals. However, limited data are available with regard to the effects of a repetitive regimen of continuous treatments of PTH followed by periodic withdrawals on the bone metabolism. We investigated the effects of this regimen by comparing the findings of intermittent and continuous PTH treatments in rats. Infusions of PTH for 24 h followed by 6-day withdrawal periods from PTH transiently increased the serum calcium levels on day 1, but these levels were within the normocalcemic range. The repetition of 4 cycles of continuous PTH infusions followed by PTH withdrawals as well as intermittent PTH treatment increased the trabecular bone thickness, osteoblast surface, and bone formation rate. Continuous PTH infusions followed by PTH withdrawals also increased the cortical thickness of the femoral diaphysis and the osteoid volume in trabecular bones, whereas the continuous treatment failed to induce these changes. These findings suggest that continuous PTH treatment followed by PTH withdrawal is a potential regimen that can induce the anabolic effects of PTH in bone metabolism without inducing hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393760     DOI: 10.1007/s00774-010-0181-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  24 in total

1.  The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.

Authors:  H Dobnig; R T Turner
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

2.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

3.  Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.

Authors:  H Z Ke; V W Shen; H Qi; D T Crawford; D D Wu; X G Liang; K L Chidsey-Frink; C M Pirie; H A Simmons; D D Thompson
Journal:  Bone       Date:  1998-09       Impact factor: 4.398

4.  Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.

Authors:  Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Mushtaq A Syed; Adolfo Garcia-Ocaña; Alessandro Bisello; Bruce W Hollis; Clifford J Rosen; John J Wysolmerski; Pamela Dann; Caren Gundberg; Andrew F Stewart
Journal:  J Bone Miner Res       Date:  2005-06-06       Impact factor: 6.741

5.  Rationale, objectives and design of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) study.

Authors:  Paul D Miller; Stuart L Silverman; Deborah T Gold; Kathleen A Taylor; Peiqi Chen; Rachel B Wagman
Journal:  Osteoporos Int       Date:  2005-06-25       Impact factor: 4.507

6.  Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.

Authors:  J M Hock; I Gera; J Fonseca; L G Raisz
Journal:  Endocrinology       Date:  1988-06       Impact factor: 4.736

7.  Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.

Authors:  Dennis M Black; Mary L Bouxsein; Lisa Palermo; Joan A McGowan; David C Newitt; Eyal Rosen; Sharmila Majumdar; Clifford J Rosen
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

8.  Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.

Authors:  I Katz; M Li; I Joffe; B Stein; T Jacobs; X G Liang; H Z Ke; W Jee; S Epstein
Journal:  J Bone Miner Res       Date:  1994-01       Impact factor: 6.741

9.  Influence of the dosing frequency of parathyroid hormone-(1-38) on its anabolic effect in bone and on the balance of calcium, phosphorus and magnesium.

Authors:  J L Riond; I Goliat-von Fischer; B Küffer; A Toromanoff; R Forrer
Journal:  Z Ernahrungswiss       Date:  1998-06

10.  Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts.

Authors:  Xin Li; Ling Qin; Marika Bergenstock; Laura M Bevelock; Deborah V Novack; Nicola C Partridge
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

View more
  6 in total

1.  The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization.

Authors:  Kevin W-H Lo; Ho Man Kan; Keshia M Ashe; Cato T Laurencin
Journal:  J Tissue Eng Regen Med       Date:  2011-02-10       Impact factor: 3.963

2.  Teriparatide Therapy as an Adjuvant for Tissue Engineering and Integration of Biomaterials.

Authors:  Robinder S Dhillon; Edward M Schwarz
Journal:  J Mater Res       Date:  2011-06-01       Impact factor: 3.089

3.  Runx1 is critical for PTH-induced onset of mesenchymal progenitor cell chondrogenic differentiation.

Authors:  Jinwu Wang; Xudong Wang; Jonathan D Holz; Timothy Rutkowski; Yongjun Wang; Zhenan Zhu; Yufeng Dong
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

4.  Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats.

Authors:  Aya Takakura; Ji-Won Lee; Kyoko Hirano; Yukihiro Isogai; Toshinori Ishizuya; Ryoko Takao-Kawabata; Tadahiro Iimura
Journal:  Bone Res       Date:  2017-04-25       Impact factor: 13.567

Review 5.  Calcitonin: A useful old friend.

Authors:  Akash Srinivasan; Felyx K Wong; Dimitrios Karponis
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-12-01       Impact factor: 2.041

6.  Effect of PTH and corticotomy on implant movement under mechanical force.

Authors:  Jiyeon Kim; Heon-Young Kim; Won-Ho Kim; Jin-Woo Kim; Min-Ji Kim
Journal:  BMC Oral Health       Date:  2020-11-10       Impact factor: 2.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.